Shares of Eleven Biotherapeutics Inc. (NASDAQ:EBIO) saw strong trading volume on Tuesday . 4,686,012 shares were traded during trading, an increase of 68% from the previous session’s volume of 2,782,337 shares.The stock last traded at $3.57 and had previously closed at $3.08.

The stock’s 50 day moving average is $2.28 and its 200 day moving average is $1.11. The firm’s market cap is $53.57 million.

In related news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $2.74, for a total transaction of $2,855,080.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.